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Blood vessels experience complex hemodynamics marked by three-dimensionality and 
pulsatility. Arterial endothelial cells interact with the characteristics of the fluid wall shear 
stress (WSS) to maintain homeostasis or promote disease states. In particular, the bicuspid 
aortic valve (BAV), a congenital heart valve anatomy consisting of two leaflets instead of 
three, is associated with aortic complications presumably promoted by hemodynamic 
abnormalities. While devices have been used to test this hypothesis, their capabilities are 
limited to the generation of time-varying WSS magnitude in one direction. However, the 
increased flow helicity generated by BAVs in the aorta is expected to result in increased 
WSS multidirectionality. Therefore, the objectives of this thesis were to characterize the 
magnitude and directionality of the regional WSS in a BAV aorta, and to design a 
bioreactor capable of replicating these characteristics in vitro. This device will provide new 
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1.1 The Aorta 
The aorta, the largest artery in the body, originates from the left ventricle of the 
heart. Its main function is to transport oxygenated blood to the body. Oxygenated blood 
comes from the pulmonary vein, enters the heart via the left atrium and then fills the left 
ventricle prior to ejection. When the heart contracts, the blood is ejected through the 
aortic valve to the aorta and the systemic circulation. The aorta can be divided into four 
sections: the ascending aorta, the aortic arch, the thoracic aorta and the abdominal aorta 
(Figure 1 [1]). While factors such as gender, age and body size affect the size of 
ascending aorta, the average diameter of a normal human ascending aorta is 33 mm (31.4 
mm in females, 37.4 mm in males [2] 
 The aortic wall is composed of three layers (Figure 2). Each layer serves different 
functions and has different characteristics. The inner layer is the tunica intima and is the 
interface between blood flow and the aortic wall. It continuously experiences the viscous 
fluid shear stress exerted by the blood flow. It consists of a thin layer made up of 
endothelial cells, subendothelial connective tissue and an internal elastic lamina. The 
middle layer is the tunica media, which is responsible for the contractile ability of the 
artery. It consists of multiple layers of smooth muscle cells embedded in their 
2  
extracellular matrix (ECM). Finally, the outer layer is the tunica adventitia, which 
consists of connective tissue and nerves. 
 
Figure 1. Different sections of the aorta: 1.) ascending aorta; 2.) aortic arch; 3.) thoracic 
aorta; 4.) abdominal aorta 
Figure 2. Cross-sectional view of the aortic wall. The aortic wall consists of 
three layers: 1.) tunica intima; 2.) tunica media; 3.) tunica adventitia 
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1.2 The Normal Aortic Valve  
The human heart contains four valves for achieving unidirectional blood flow. 
The aortic valve (AV) is located between the left ventricle and the aorta (Figure 3). The 
main function of the AV is to achieve unidirectional blood flow from the left ventricle to 
the aorta during systole and to prevent backflow during diastole (Figure 4). The AV is 
also known as aortic semilunar valve or tricuspid aortic valve (TAV) since the normal 
AV consists of three pocket-like semilunar cusps. The cusps, also known as leaflets, are 
referred to as the left-coronary, the right-coronary and the non-coronary leaflets, 









aortic valve  
Figure 3. Heart anatomy 
right coronary ostia  





1.3 The Bicuspid Aortic Valve  
The bicuspid aortic valve (BAV) is one of the most common congenital heart 
defect in which two aortic valve leaflets remain fused during embryonic development. 
This defect exists in 1-2% of the general population [3], [4]. Depending on the number of 
fusion sites (raphes) present between the leaflets, BAVs are categorized into three types. 







left coronary ostia right coronary ostia 
Figure 5. Short-axis view of the tricuspid aortic valve (TAV) 
Figure 4. Heart valve function: the aortic valve closes during diastole and opens 
during systole 
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raphes, respectively (Figure 6-A). The type-I BAV is the most common (88% of the BAV 
patients) [5] and can be further categorized into three morphotypes based on the position 
of the leaflet fusion: left- and right-coronary leaflet fusion (LR-BAV), right- and non-
coronary leaflet fusion (RN-BAV), and non- and left-coronary leaflet fusion (NL-BAV). 
The LR-BAV is the most prevalent morphotype and accounts for 71% of type-I BAVs, 
while the RN- and NL-BAV occur in 15% and 3% of type-I BAV cases, respectively 
(Figure 6-B) [6]–[14].  
 
 
1.4 BAV Aortopathy  
Previous research suggests that BAV is associated with secondary aortopathy, 
such as aortic dilation [15], aortic aneurysm [16] and aortic dissection [17]. Aortic 
dilation, the precursor of aortic aneurysm, results from vascular smooth muscle cell 
(VSMC) apoptosis, elastic fiber degeneration and abnormal ECM remodeling [18]. 
A 
B 
type-0 type-I type-II 
L L L R R R 
N N N 
7% 88% 5% 
LR (71%) RN (15%) NL (3%) 
raphe raphe 
Figure 6. BAVs exist in three types: A.) type-0 (no raphe), type-I (one raphe) and 
type-II (two raphes); Type-I BAVs are further categorized into three morphotypes: B.) 
LR-BAV, RN-BAV and NL-BAV 
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1.4.1   Ascending Aortic Dilation  
Aortic dilation is an abnormal enlargement of the aorta. Although both TAV and 
BAV patients can develop ascending aortic dilation, BAV patients are at higher risk of 
developing the disease [17], [19], [20] and the dilation patterns are quite different. When 
aortic dilation develops in the AA of TAV patients, it is usually symmetric. In contrast, 
asymmetric dilation patterns are usually observed in BAV AAs (Figure 7)[21]. The 
incidence of aortic dilation in TAV patients with hypertension and BAV patients is 12% 
and 35-68%, respectively [17], [19], [20]. Furthermore, BAV patients experience more 
rapid dilation progression rate (0.2-1.9 mm/yr) than TAV patients (0.07-0.2 mm/yr) [22].  
 
AA dilation has been further categorized into three phenotypes based on the 
location of the dilation on the AA: aortic root (type-1), tubular portion of the AA (type-
2), and the entire AA and the transverse aortic arch (type-3) [23]. Previous studies aimed 
at investigating the relationship between BAV morphotypes and dilation phenotypes 
through echocardiography and cardiac magnetic resonance (CMR) have indicated that 
LR-BAV patients are prone to develop type-1 dilation (18 out of 92 LR-BAV patients) 
and that type-1 dilation is exclusively observed in LR-BAV patients. In contrast, RN-
Figure 7. Aortic dilation patterns in A.) TAV; and B.) BAV aortas 
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BAV patients are more likely to develop type-2 and type-3 dilation (24 out of 41 RN-
BAV patients) (Figure 8) [24], [25]. 
 
 
1.4.2   Aortic Dilation Pathobiology  
VSMCs Apoptosis and Deficiency of Fibrillin-1 
 Previous biochemical studies have quantified the rate of VSMC apoptosis and the 
levels of fibrillin-1, collagen and elastin in the aortic media of both TAV and BAV 
patients. BAVs have been associated with a higher rate of VSMCs apoptosis than TAVs, 
Figure 8. BAV morphotypes and their corresponding aortic dilation phenotype. 
The circled numbers indicate the number of cases shift from one phenotype to 
the other found in follow-up examination. 
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especially in the convexity of the aorta [26]. Furthermore, the levels of type-I/III collagen 
measured in the convexity of BAV aortas where the dilation is prone to occur are lower 
than in TAV aortas. Greater elastic fragmentation and less VSMCs have been observed in 
the convexity as compared with the concavity of BAV aortas [27].  
 VSMCs are the major components of the tunica media and play an important role 
in maintaining the structural integrity of the aorta. The two primary functions of the 
VSMCs are 1.) to regulate the contraction of the vessel when mechanical stimuli are 
sensed, and 2.) to synthesize ECM, which includes collagen, elastin, laminin, 
proteoglycan, fibrillin, fibronectin and tenascin [28], [29].  
 Fibrillin-1, a glycoprotein, is the main component responsible for the structural 
integrity of the aortic wall. Fibrillin-1 is required to bind VSMCs to the elastin/collagen 
matrix. VSMC apoptosis occurs when the media is deficient in fibrillin-1, which causes 
VSMCs to dissociate from the elastin/collagen matrix, resulting ultimately in a loss of 
vessel structural integrity [4], [30].  
 
Elastic Fiber Degeneration and ECM Remodeling  
Matrix metalloproteinases (MMPs) are a type of enzymes that digest matrix 
proteins and are synthesized by the cellular components of the vessel wall and 
inflammatory cells. Previous studies have suggested that BAV aortic dilation may be 
related to the high activity of MMPs, especially MMP-9. The release of MMP-9 can be 
activated either when the levels of tissue inhibitor of metalloproteinases (TIMPs) are 
decreased [31], [32] or when the transforming growth factor-beta (TGF-β) cascade is 
triggered [33]. On the other hand, MMP-9 are two of the downstream targets of the TGF-
9  
β pathway. Once the TGF-β cascade is triggered, MMP-9 activity is increased, leading in 
turn to degradation of type IV collagen, elastin and fibrillar collagens, and causing ECM 
remodeling, which eventually leads to aortic dilation [4], [34].  
 
1.5 Aortic Dilation Diagnosis and Treatment 
The average diameter of a normal human AA is 33 mm. AA aneurysm is usually 
diagnosed either when the diameter of the dilated aorta is equal to or greater than 1.5 
times the normal average diameter, or when the diameter exceeds 5 cm [35].  
Depending on the severity of the aneurysm, surgery might be recommended. There are 
two methods to treat ascending aorta aneurysm. The first method is reduction aortoplasty, 
in which the dilated aorta is cut open, a section of the aortic wall is trimmed off and the 
aorta is closed by suturing [36] (Figure 9 [6]–[14]). The second method is the Dacron 
graft method and consists of replacing the dilated site of the aorta with a tube-shaped 
Dacron graft made of synthetic material (Figure 10). 
Figure 9. Reduction aortoplasty. A.) The enlarged, excessive aortic tissue in oval shape 
is excised from the convexity of the AA, and B.) the opening is sutured to close. 
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1.6 BAV Hemodynamics  
Multiple studies have investigated the flow field in BAV AAs and its potential 
role in aortopathy through in vivo [13], [37]–[41], in vitro [8], [42], and computational 
[43], [44] techniques.  
 
1.6.1  In Vivo Studies 
Barker et al. performed clinical measurements using phase-contrast magnetic 
resonance imaging (PC-MRI) to compare the regional WSS in TAV and BAV aortas 
[13], [37]. The studies revealed that BAVs are associated with increased circumferential 
WSS, and that LR-BAVs result in flow impingement on the right-anterior AA. 
Retrograde, asymmetric flow patterns were also observed in BAV aortas.  
Other studies conducted by Hope and colleagues aimed at investigating the flow 
patterns and WSS abnormalities in BAV AAs via 4D PC-MRI [40], [41]. The studies 
Figure 10. Dacron Graft. A synthetic polyester tube which is used 
for replacing and repairing blood vessels. 
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reported that BAVs cause eccentric, helical flow patterns at peak systole in the AA, with 
asymmetrically elevated WSS. The results also evidenced that, although type-I BAVs 
cause helical flow in the AA, the flow patterns and the location of flow impingement on 
the AA wall are strongly dependent on the BAV morphotype. The LR-BAV generates 
right-handed helical flow in the AA and causes the flow to impinge on the right-anterior 
portion of the AA. In contrast, the RN-BAV generates left-handed helical flow and 
results in flow impingement at the left-posterior portion of the AA. Similar results were 
found in studies performed by Bissell et al. [39] and Mahadevia et al [38].  
Bissel et al. attempted to identify the relationship between flow abnormalities and 
aortic dilation via CMR analysis over a large sample size (95 BAV patients and 47 
healthy volunteers). The results demonstrated that BAVs are linked to abnormal, higher 
right-handed helical flow, higher systolic WSS and larger AAs as compared to the normal 
TAV. It was also demonstrated that the abnormal flow in BAV patients occurs before the 
development of aortic dilation, suggesting that the abnormal flow might induce 
aortopathy [11].  
Using 4D MRI, Mahadevia et al. demonstrated that BAVs cause eccentric outflow 
jet patterns in the AA, which result in increased regional WSS. The locations of jet 
impingement were the right-anterior wall in LR-BAV patients and the right-posterior 




1.6.2  In Vitro Studies 
 Particle image velocimetry (PIV) has been used to characterize quantitively and 
qualitatively the flow field in TAVs and BAVs. By performing this in vitro analysis, 
Saikrishnan et al. attempted to measure and characterize the flow environment generated 
Figure 11. Comparisons of the flow patterns in A.) healthy volunteer; B.) aorta size 
control; C.) LR-BAV AA; D.) RN-BAV AA. The flow pattern in the healthy 
volunteer follows streamline. In contrast, the flow patterns are helical, and the jet 
impinged at the right-posterior aortic wall regions in the LR-BAV and RN-BAV, 
respectively. 
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by TAVs and LR-BAVs. They first aimed at studying the impact of jet eccentricity by 
varying the level of stenosis on the BAV [9]. Other factors, such as jet angle, jet velocity 
and aortic dilation, which may also exist in BAV patients, were taken into account in a 
follow-up study [45]. The results demonstrated that BAVs generate increased systolic jet 
velocity and flow impingement on the convexity of the AA wall, which results in a strong 
vortex in the non-fused leaflet sinus. Moreover, increase in the level of turbulence and 
WSS was also observed in BAVs relative to TAVs.  
 Other studies investigating the BAV flow characteristics through PIV experiments 
were conducted by Seaman et. al. [8] and McNally et al. [42]. Seaman et. al. aimed at 
quantifying the energy loss through the valve. The experiment was performed under 
steady peak-systolic flow with normal and calcified TAVs and LR-BAVs. The results 
revealed that BAVs are associated with higher energy loss relative to TAVs and result in 
an elliptical orifice, which causes the jet to skew toward the non-coronary leaflet [8]. 
McNally and colleagues aimed at distinguishing the flow characteristics caused 
by each type-I BAV morphotype (i.e., LR-BAV, RN-BAV and NL-BAV) under native 
pulsatile flow. Both LR-BAVs and NL-BAVs resulted in increased peak-systolic orifice 
jet velocity and WSS overloads on the AA convexity relative to TAVs [42]. 
 
1.6.3  Computational Studies 
 
Computational fluid dynamics (CFD) and fluid-structure interaction (FSI) 
modeling have been widely used for the hemodynamics characterization of blood vessels 
at higher spatial and temporal resolutions than conventional imaging techniques such as 
Doppler echocardiophy and PC-MRI [46]–[48]. 
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Previous in vivo study has revealed that the degree of jet skewness is proportional 
to the AA diameter and the severity of aortic dilation [49]. Faggiano et al. aimed at 
linking these findings to BAV flow characteristics during systole through computational 
analysis [14]. CFD aorta models were constructed based on PC-MRI images of TAV and 
BAV patients with varying valve orifice area and degree of aortic dilation. The results 
demonstrated that the narrower orifice is, the more skewed the orifice jet would be. 
Asymmetric jet was only observed in BAV cases, and all of them were reported with high 
flow helicity and high systolic WSS magnitude in the AA. 
Instead of studying flow characteristics in BAV aortas with pre-existing dilation, 
Cao and colleagues designed TAV and type-I BAV aorta FSI models to quantify the 
influence of the valve structure on the downstream hemodynamic environment in a 
normal non-dilated AA. The results demonstrated that type-I BAV morphotypes cause 
WSS overload on the AA convexity at peak systole, and WSS unidirectionality was 
higher in the convexity of the proximal AA in all BAVs. The fact that BAVs cause 
asymmetric helical flow and systolic WSS overload on the convexity of the AA was 
confirmed [43]. 
Kimura et al. performed a patient-specific CFD analysis aimed at analyzing the 
flow patterns and WSS distributions in TAV/BAV aortas [38]. The study revealed that 
although the flow patterns in BAV patients differed greatly, abnormal helical flow was 
present in the AA and transverse arch of all BAV patients. Furthermore, right-handed 
helical flow was present in 91% of BAV aortas. Elevated WSS on the convexity of BAV 
AAs and asymmetric flow in the BAV AAs were also detected. Notably, 3 out of the 4 
LR-BAV patients and 1 out of the 2 RN-BAV patients exhibited flow impingement and 
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elevated WSS on the right anterior wall and right posterior wall, respectively [44]. This 
confirmed the flow characteristics reported by Mahadevia et al [18]. 
 
1.7 Etiologies of BAV Aortopathy 
1.7.1 Genetic and Hemodynamic Etiologies 
Two etiologies have been proposed to explain the link between BAV and 
aortopathy. One suggests that BAV secondary aortopathy is genetic, while the other 
suggests that it can also be due to abnormalities in the hemodynamic environment. The 
abnormal blood flow and WSS generated by BAVs could trigger critical biological 
processes (e.g., ECM remodeling, VSMC apoptosis, fibrillin-1 depletion [18], [21], [27]) 
leading ultimately to aortic dilation (Figure 12 [50]). Other studies have suggested the 
existence of correlations between those hemodynamic abnormalities, the asymmetric 
patterns of the aortic dilation on the convexity of the ascending aortic wall, and aortic 
medial degradation [51].  
Figure 12. Hemodynamic theory of BAV AA dilation 
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1.7.2 Supporting Evidence of the BAV Hemodynamic Theory 
  As mentioned earlier, aortic dilation is a result of a series of biochemical 
processes involving VSMC apoptosis, elastic fiber degeneration and abnormal ECM 
remodeling [52]. These biological events are regulated by the expression and activity of 
certain proteins and enzymes (i.e., fibrillin-1, TGF-β, MMP-2, MMP-9, TIMPs, etc.). 
Biological analyses have been performed to investigate the levels/activities of these 
components in TAV and BAV aortas. Fedak et al. and Boyum et al. analyzed TAV and 
BAV aortic tissue samples using immunohistochemistry, fluorescence microscopy and 
gelatinase zymography. The results revealed that BAV aortas exhibit decreased levels of 
fibrillin-1 expression and increased MMP-2/9 activity relative to TAV aortas [53], [27].  
To determine the role played by those proteins and enzymes in aortic dilation, 
Cotrufo et al. [54] and Della Corte et al. [13], [37]–[41] performed comparative 
biological analyses on the convexity and concavity of TAV and BAV aortas. Decreased 
levels of type-I and type-III collagens and increased level of type-IV collagen were 
observed in dilated BAV aortas relative to TAV aortas. Those changes were more 
significant in the convexity of BAV aortas than in the concavity. Also, increased VSMC 
apoptosis was detected in the convexity of BAV aortas. These studies concluded that 
BAV aortas exhibit asymmetric ECM expression and increased VSMC apoptosis in the 
AA convexity, which correlate with the asymmetric flow patterns evidenced by in vivo 
[8], [42], in vitro [43], [44], and computational studies [21].  
To demonstrate that abnormal WSS exerted on the convexity of the AA triggers 
biological events and leads to aortic dilation, ex vivo biological experiments have been 
conducted to investigate the acute biological response of porcine aortic tissue subjected to 
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TAV and BAV WSS. These studies revealed increased MMP-2 and 9 levels following 
tissue conditioning to WSS from the convexity of the BAV AA [55]. In contrast, there 
was no significant difference in MMP-2 level when subjecting porcine aortic tissue to the 
WSS from the TAV/BAV AA concavity [56].  
Collectively, these studies provide preliminary supporting evidence for the role 











The BAV is a congenital valvular defect resulting from the fusion between two 
leaflets [43]. While in vivo, in vitro and computational studies have evidenced that BAV 
can cause helical flow patterns and abnormal WSS in the AA [57], previous flow 
characterizations have focused on the quantification of the total or longitudinal WSS in 
terms of magnitude and pulsatility [57]–[59]. The demonstrated increased helicity of 
BAV flow is expected to generate a significant circumferential WSS component, whose 
characteristics to date remain largely unknown. In addition, aortic cells respond to 
hemodynamic stress abnormalities by activating critical biological processes, which may 
lead to aortopathy. The elucidation of the cause-and-effect relationships between BAV 
flow and aorta biology requires a device capable of subjecting native aortic tissue to its 
local hemodynamic stress environment.  
Different fluid shear stress bioreactors, such as the parallel plate flow chamber, 
microfluidic devices and the cone-and-plate bioreactor, have been designed and used to 
expose tissue samples to desired fluid shear stress environment [58]. Although those 
bioreactors are capable of subjecting tissue samples to desired WSS magnitude, their 
ability to replicate the actual native hemodynamic environment faces some limitations. 
The native hemodynamic environment often involves time-dependent pulsatile WSS 
magnitude and directionality. The parallel flow chamber can only produce shear stress at 
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a constant magnitude. In fact, the fluid volume required to fill the bioreactor is typically 
large, creating challenges in generating a pulsatile WSS due to the high fluid inertia [59], 
[60].  
Microfluidic devices have also been used to expose cells to desired WSS 
magnitude. Such devices usually consist of a pump and cell culture chambers filled with 
fluid. Pumps are used to push the fluid into/out of the chamber. The flow generated in the 
chamber is Poiseuille flow, which results in uniform shear stress distribution on the 
bottom surface of the chamber. However, such devices are usually designed with small 
dimensions (e.g., 24-100 µm in depth and 200 µm in width) since their purpose is to 
subject a cell monolayer to fluid shear stress [61], [62], limiting their application to the 
conditioning of tissue. 
The cone-and-plate bioreactor consists of an inverted rotating cone and a 
stationary plate in which tissue samples are mounted. Culture medium fills the gap  
between the cone and plate. When the cone rotates, fluid flow and uniform shear stress 
are generated on top of the plate and tissue. Such device is capable of generating 
temporal variations in WSS magnitude. However, the WSS generated is along the 
circumferential cone direction, which prevents the replication of a multidirectional WSS 
[5]. Hence, a new bioreactor is required to replicate the changes in magnitude and 
directionality of the local WSS on native aortic tissue.  
Therefore, the objectives of this thesis were to quantify the multidirectional 
characteristics of the WSS caused by BAVs in the AA and to design a device capable 
of subjecting native aortic tissue to native BAV WSS magnitude and directionality. 
The quantification of WSS multidirectionality is described in Specific Aim 1, the design 
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of the bioreactor is described in Specific Aim 2 and the determination of the device 
operating conditions is described in Specific Aim 3.  
 
Specific Aim 1: To quantify the multidirectional characteristics of BAV aorta WSS 
in regions prone to dilation  
Local WSS waveforms were obtained from valve-aorta FSI models published by 
our group [21], [63]. The local WSS was characterized over two circular regions (7 mm 
in diameter) located in the proximal section of the AA convexity and concavity. The 
instantaneous WSS vector was extracted and decomposed into its longitudinal and 
circumferential components. WSS multidirectionality was then quantified in terms of 
temporal shear magnitude (TSM) and oscillatory shear index (OSI) in both directions, 
and transverse WSS (transWSS). TSM and OSI are two frequently used indices for 
quantifying the time-averaged magnitude and the oscillation nature of shear stress. 
TransWSS is a new index for evaluating the multidirectionality of the flow by calculating 
the instantaneous WSS components perpendicular to the direction of the mean WSS.  
 
Specific Aim 2: To design a cone-and-plate bioreactor replicating the temporal 
changes in WSS magnitude and directionality of BAV aortic tissue 
The design was adapted from the cone-and-plate viscometer principle to subject 
aortic tissue to desired time-varying WSS magnitude and direction. The device was 
designed to accommodate four circular tissue samples. WSS magnitude was adjusted by 
rotating an inverted cone above the culture medium, resulting in a fluid flow of culture 
medium above the tissue specimens, and a WSS directly proportional to the cone 
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velocity. Temporal changes in WSS directionality on each sample were achieved by 
rotating the mounts supporting the tissue specimens. Computer-aided design (CAD) 
drawings for each part of the physical model were created.  
 
Specific Aim 3: To determine the bioreactor operating conditions 
 This aim consisted of determining: 1.) the optimal dimensions of the bioreactor, 
2.) appropriate operating conditions, and 3.) the torque requirements for servo motor 
selection. For the first task, CFD simulations were performed to assess the impact of 
tissue location and cone radius on the validity of the equation relating cone velocity and 
WSS. The predicted WSS magnitude and directionality were compared to the target WSS 
extracted from the convexity of the LR-BAV AA (Specific Aim 1) over a range of cone 
radii and tissue positions, and optimal bioreactor dimensions were determined based on 
the correlation coefficient between the target and predicted WSS. The second task 
implemented an iterative optimization method to determine the bioreactor operating 
conditions (cone angular velocity waveform, tissue angular velocity waveform) resulting 
in the desired WSS environment. Lastly for task 3, torque requirements were calculated 





SPECIFIC AIM 1 
 
3.1 Rationale 
BAVs cause helical flow patterns and elevated WSS in the AA. Previous studies 
have typically focused on characterizing BAV WSS abnormalities in terms of magnitude 
and pulsatility abnormalities in global or longitudinal WSS [57]–[59]. Since the 
circumferential WSS is a significant component in helical flows, substantial 
abnormalities in circumferential WSS are also expected in BAV AAs. The quantification 
of this component was thus required to provide the full characterization of WSS 
abnormalities in BAV AAs.  
 
3.2 Methods 
3.2.1  TAV/BAV Aorta Fluid-Structure Interaction (FSI) Models 
 The FSI models used in this thesis were published previously by our lab. The 
models consisted of four aortic valve geometries (TAV, LR-BAV, RN-BAV and NL-
BAV) connected to an idealized aorta reconstructed from a series of computed 
tomography images of a human aorta [64]. The aorta geometry included the AA and the 
aortic arch along with the entrance regions of the brachiocephalic (BCA), left common 
carotid (LCCA), and left subclavian (LSA) arteries. The four valves consisted of one 
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TAV geometry with three identical leaflets, and the three type-I BAV geometries with the 
raphe placed along the common free edge of the fused leaflets (Figure 13) [43], [65]. The 
compliance of the valve leaflets and the aortic wall was modeled using a three-parameter 
Mooney-Rivlin model and a linear elastic model, respectively, calibrated with respect to 
published tensile test data on valvular and aortic tissue [43]. Blood was modeled as an 
incompressible, homogeneous and Newtonian fluid (density: 1050 
3kg/m ; dynamic 
viscosity: 0.0035 Pa s ). Fully coupled, two-way FSI simulations were performed in 
ANSYS 18.0 Fluent, Mechanical ADPL and System Coupling (ANSYS Inc) using the 
arbitrary Lagrangian-Eulerian (ALE) approach. The governing equations consisted of the 
momentum and continuity equations for the fluid domain, the momentum equation for 
the structural domain, and three coupling conditions enforcing continuity of 
displacements, velocities and tractions at the fluid-structure interface. All models were 
subjected to the same physiologic transvalvular pressure waveform (0/12 mmHg, 2:1 
diastolic/systolic ratio). The simulations predicted a cardiac output of 4.5 L/min for the 
TAV aorta, and 4.0 L/min for the BAV aorta models, respectively [66], [67], which fall 









3.2.2  Longitudinal and Circumferential WSS Extraction 
The WSS characterization was conducted in two circular target regions (7-mm 
diameter) located in the convexity and concavity of the proximal AA section (Figure 14-
A). The surface-averaged WSS was extracted at each time step over one cardiac cycle. 
The vector was then decomposed into its instantaneous longitudinal and circumferential 
components, 
long  and circ  , respectively, following the procedure outlined below.  
The longitudinal direction was identified as the normal unit vector k̂  to the cross 
section of the aorta intersecting the two target regions (Figure 14-B). For each 
interrogation region, the unit vector in the circumferential direction θ̂  was obtained as 
the cross product between the outward unit normal vector n̂  to the target region and the 
Figure 13. Valve-aorta FSI models. A.) TAV; B.) LR-BAV; C.) RN-BAV; 
D.) NL-BAV 
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longitudinal unit vector: 
 ˆ ˆˆ= θ n k  (1) 
 
As a result of this calculation, the circumferential direction always pointed in the 
clockwise direction along the aortic wall, regardless of the location of the interrogation 
region. Lastly, the local longitudinal and circumferential WSS components were obtained 
by calculating the dot product between the local WSS vector and the respective unit 
vector in each direction: 
 ˆ
long = τ k  (2) 
and 
 ˆ
circ = τ θ  (3) 
 
3.2.3 WSS Characterization 
 The temporal changes in magnitude and direction of the local WSS vector τ  were 
assessed qualitatively by plotting the trace of the tip of the vector on a polar plot. The 
Figure 14. WSS extraction A.) at the convexity and concavity; B.) in longitudinal 
and circumferential directions. 
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average magnitude of the total, longitudinal and circumferential WSS over one cardiac 








=   (4) 
where , ,i total long circ    =    and T  is the cardiac period. The change in directionality of 
the WSS vector and the oscillatory nature of each component were quantified in terms of 


























The multidirectional characteristics of the flow were also assessed in terms of the 
transverse WSS (transWSS), which indicates the degree of deflection of the WSS vector 

























The value of the transWSS ranges from 0 to the total TSM. If the WSS vector oscillates 
along the direction of the mean WSS vector over the entire cardiac cycle, then the flow is 
unidirectional and transWSS is close to 0. If a large portion of the instantaneous WSS 
vectors deviates from the mean WSS vector and contributes more toward the direction 
perpendicular to the mean vector, the flow is relatively multidirectional. The closer the 
transWSS value to its total TSM, the more multidirectional the flow is. 
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3.2.4 WSS Angular Variations 
 WSS overload has been reported at the convexity of the AA from previous 
studies. To assess the directionality of the elevated WSS, the temporal variations of WSS 
orientation at the convexity over the entire cardiac cycle were evaluated by calculating 
the angle ( ) between the longitudinal axis and the WSS vector at each time point. To 
calculate  , the instantaneous WSS vector was first projected to the longitudinal axis by 
performing inner product on these two vectors (Equation 7). Then, the angle at each time 



















Angular variation was captured in full 360  range on the interrogation region over 
the entire cardiac cycle, essentially quantifying the instantaneous WSS change in 
direction at one specific location. This waveform was then equally segmented into 36 
sectors along a unit circle, with instantaneous WSS sorted into the corresponding sectors 
based on its angle orientation. The average WSS magnitude was then calculated for each 
segment, and set as its dominant value.  
To adequately quantify the change in direction associated with significant WSS 
magnitudes, a criterion was established for all morphotypes. The maximum value was 
selected amongst all geometries, and WSS quantity was normalized to it. WSS was 
considered significant when the value exceeds 50% of the maximum WSS magnitude 
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found among all the morphotypes. Polar histograms were created and used to identify the 
angle distribution of the abnormal WSS magnitude (i.e., when the WSS magnitude is 
50% larger than the maximum WSS among all morphotypes). The more quantities of 
sectors exceed this 50% criterion are obtained means the larger range of angles the WSS 
orientation covers.  
  
3.3 Results 
3.3.1 WSS Orientation and Angular Variations  
The time history of the WSS vectors predicted in the convexity and concavity of 
the proximal AA for the four valves are provided as videos in Appendix A and as polar 
plots in Figure 15. While the results suggest that all valves subject the proximal aortic 
wall to substantial changes in WSS directionality, TAV and BAV WSS differ in their 
range of rotation and overall magnitude.  
To examine the angle distribution without considering the WSS magnitude, the 
TAV resulted in a wider range of WSS angles in the convexity than the BAVs (see Table 
1).  The TAV WSS vectors in the convexity and concavity were oriented at an average 
angle of 286  and 55  , respectively, relative to the longitudinal direction over the cardiac 
cycle. In the BAV aortas, the increased flow helicity tended to align the WSS vectors 
along the circumferential direction (convexity WSS average angle: 255  ; concavity WSS 
average angle: 185  ). 
However, when taking the WSS magnitude into consideration (Figure 16), the 
majority of the sectors in TAV polar plot fell within 50% of the maximum WSS 
magnitude criterion among all morphotypes. Since TAV represented the normal 
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physiologic case, sectors with WSS magnitude exceeded this 50% criterion is considered 
as significant overload. All BAVs exhibited elevated WSS magnitude in the proximal AA 
convexity, and those levels were experienced over a wide range of angles (Figure 17). 
The range of the angles for each model is listed in Table 2. 
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Figure 15. WSS magnitude vs. orientation in proximal convexity and concavity of A.) 
TAV, B.) LR-BAV, C.) RN-BAV and D.) NL-BAV aorta models 
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Table 1. Angle distribution in the convexity of the AA of all models 
 TAV LR-BAV RN-BAV NL-BAV 
Range of 
Angles 
180  130  150  160  
 
Table 2. Width of WSS angle range for WSS magnitudes exceeding 50% of the 
maximum WSS at the proximal convexity for all models 
 TAV LR-BAV RN-BAV NL-BAV 
Range of 
Angles 
10  30  50   40  
Figure 16. Angular distribution of normalized mean WSS magnitude at the proximal 
convexity of the A.) TAV; B.) LR-BAV; C.) RN-BAV and D.) NL-BAV aortas. The 




3.3.2 WSS Magnitude Characteristics 
 WSS characteristics were quantified in the proximal AA convexity and concavity 
of TAV and BAV AAs. Both the longitudinal and circumferential WSS components were 
examined to assess the multidirectionality of the local WSS environment. 
 
Total TSM 
The raw data of the total TSM were summarized in Table 3. The total TSM was 
higher on the proximal AA convexity downstream of a BAV than downstream of a TAV, 
Figure 17. Summary of the number of sectors satisfying each criterion at the convexity 
of AA for all valve-aorta models 
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regardless of the BAV morphotype (Figure 18). The models predicted overall WSS 
magnitude overloads in all BAV AAs (LR-BAV; 134.4% increase, RN-BAV; 105.1% 
increase, and NL-BAV; 95.6% increase with respect to the TAV). In contrast, total TSM 
calculations in the proximal concavity revealed an overall decrease in WSS magnitude 
(LR-BAV; 23.4% decrease, RN-BAV; 52.9% decrease, and NL-BAV; 32.4% decrease 
with respect to the TAV).  
An apparent trend observed was that the WSS overload on the convexity was 
higher than that in the concavity for all BAV morphotypes. Although the LR-BAV 
generated the highest values at both locations, the overload observed in the convexity was 
substantially larger (37.8% increase) than in the concavity. The convexity of the RN-
BAV aorta experienced the most dramatic change in magnitude among all morphotypes 
(96.0% increase vs. concavity). 
 
Table 3. Total TSM (Pa) at convexity and concavity of all valve-aorta models 
 Convexity Concavity 
TAV 1.44 3.20 
LR-BAV 3.38 2.45 
RN-BAV 2.96 1.51 
NL-BAV 2.82 2.16 
 
Longitudinal TSM 
 The raw data of the longitudinal TSM were summarized in Table 4. Similar to the 
trend observed with the total TSM, the BAVs subjected the aortic wall to overloads in 
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longitudinal WSS in the proximal AA convexity (LR-BAV; 53.3% increase, RN-BAV; 
38.3% increase, and NL-BAV; 31.5% increase with respect to the TAV). Longitudinal 
TSM predictions made in the concavity exhibited the same trend as the total TSM, 
marked by an overall decrease in TSM (LR-BAV: 37.6% decrease, RN-BAV: 57.5% 
decrease, and NL-BAV: 34.8% decrease with respect to the TAV). However, a different 
pattern emerged in the concavity where BAVs generated higher longitudinal TSM than in 
the convexity (LR-BAV; 11.4% increase, RN-BAV; 17.3% decrease, and NL-BAV; 
27.3% increase with respect to the convexity).  
 
Table 4. Longitudinal TSM (Pa) at convexity and concavity of all valve-aorta models 
 Convexity Concavity 
TAV 0.96 2.67 
LR-BAV 1.48 1.67 
RN-BAV 1.33 1.14 
NL-BAV 1.27 1.74 
 
Circumferential TSM 
The raw data of the circumferential TSM were summarized in Table 5. All BAV 
morphotypes generated significant overloads in circumferential TSM on convexity of the 
AA (LR-BAV: 242.4% increase, RN-BAV: 194.0% increase, and NL-BAV; 180.7% 
increase with respect to the TAV). Furthermore, the circumferential TSM values are 
larger than the longitudinal TSM shown in Figure 18, suggesting that the circumferential 
WSS is the dominant component in the convexity of all BAV AAs.   
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 As compared to the proximal convexity, the concavity of BAV AAs exhibited an 
overall decrease in circumferential TSM (LR-BAV: 47.9% decrease, RN-BAV: 70.3% 
decrease, NL-BAV: 57.4% decrease vs. convexity). To compare the circumferential TSM 
and the longitudinal TSM in the concavity of AA for all models, the longitudinal TSM is 
higher than circumferential TSM for all models. That is, the flow is dominated by the 
longitudinal component in the concavity for all valve-aorta models.  The only exception 
is with the LR-BAV morphotype for which both stress components are essentially similar 
(longitudinal TSM: 1.67 Pa; circumferential TSM: 1.48 Pa), suggesting the strong 
multidirectionality of the WSS environment generated by this morphotype. 
 
Table 5. Circumferential TSM (Pa) at convexity and concavity of all valve-aorta models 
 Convexity Concavity 
TAV 0.83 1.59 
LR-BAV 2.85 1.49 
RN-BAV 2.45 0.73 











3.3.3 WSS Directionality Characteristics 
The WSS directionality was characterized in terms of OSI and transWSS. was 
quantified in the longitudinal and circumferential directions, in both the proximal AA 
convexity and concavity for all valves. The OSI in the longitudinal and circumferential 
directions were abbreviated as LOSI and COSI, respectively. The results are summarized 




Figure 18. Total, longitudinal and circumferential TSM at the convexity and 
concavity of the proximal AA 
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Longitudinal OSI 
In the proximal AA, all models generated WSS oscillation in the longitudinal 
direction (Table 6). This is likely due to the successive forward and backward flows 
generated during systole and diastole, respectively. Furthermore, the largest LOSI was 
observed in the TAV AA. To be more specific, the LR-BAV, RN-BAV and NL-BAV 
resulted in a 0.10-point, 0.17-point and 0.10-point decrease in LOSI in the convexity, 
respectively, relative to the TAV. Among all BAV morphotypes, the RN-BAV predicted 
the highest LOSI in the concavity. 
The comparison of the OSI predictions in the convexity and concavity of BAV 
AAs reveals that both the LR- and NL-BAV subjected the convexity to higher LOSI than 
the concavity (LR-BAV: 0.04-point increase; NL-BAV: 0.06-point increase vs. 
concavity). This trend was opposite with the RN-BAV, which subjected the wall 
convexity to lower LOSI than the concavity (0.12-point decrease). 
 
Circumferential OSI 
COSI values extracted in the AA convexity of all models were close/equal to zero 
(Table 7), suggesting the absence of back-and-forth oscillation of the circumferential 
WSS component. In contrast, while all BAVs generated oscillatory WSS in both 
longitudinal and circumferential directions in the proximal AA concavity (LOSI > 0.22, 
COSI > 0.32), the TAV only generated oscillations in longitudinal WSS (LOSI = 0.30, 
COSI = 0.02).  
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Table 6. Longitudinal OSI at convexity and concavity of all valve-aorta models 
 Convexity Concavity 
TAV 0.38 0.30 
LR-BAV 0.28 0.24 
RN-BAV 0.21 0.33 
NL-BAV 0.28 0.22 
 
Table 7. Circumferential OSI at convexity and concavity of all valve-aorta models 
 Convexity Concavity 
TAV 0.02 0.02 
LR-BAV 0.00 0.40 
RN-BAV 0.00 0.40 
NL-BAV 0.00 0.32 
 




 The raw data of the transWSS and its ratio to the total TSM in the proximal AA for all 
models are reported in Table 8. The higher the ratio, the greater the flow multidirectionality. In 
the convexity of the proximal AA, all BAVs generated relatively low WSS directionality 
(transWSS/total TSM ratio < 37.6%) relative to the TAV (transWSS/total TSM ratio = 
61.1%). In contrast, all models resulted in relatively high WSS directionality in the 
concavity (transWSS/total TSM ratio > 70.9%).  
 
Table 8. transWSS and transWSS/total TSM ratio in the convexity and concavity of all 
valve-aorta models.  
 Convexity Concavity 
 transWSS (Pa) Ratio transWSS (Pa) Ratio 
TAV 0.88 61.1% 2.27 70.9% 
LR-BAV 1.27 37.6% 1.76 71.8% 
RN-BAV 0.84 28.4% 1.18 78.1% 




3.4  Summary 
 WSS overloads were observed in the proximal convexity of all BAV AAs, with 
the LR-BAV generating the most substantial increase. While both longitudinal and 
circumferential TSM were increased in BAV AAs, the circumferential WSS component 
dominates over the longitudinal component.  
 The multidirectionality of the WSS in the convexity was analyzed through 
characterization of the angular distribution of the sectors. All BAV AAs exhibited wider 
WSS angular ranges and larger WSS levels relative to the TAV AA. Asymmetric WSS 
directionality patterns were observed in which high transWSS was observed in the 
convexity of the TAV AA and the concavity of all models, while relatively lower 
transWSS was obtained in the convexity of all BAV AAs. 
Figure 20. Ratio of transWSS and total TSM in the convexity and concavity of the 





SPECIFIC AIM 2 
 
4.1 Rationale 
Previous in vivo studies [13], [21], [38], [40], [41], [70], [71] have suggested that 
the WSS overload caused by BAVs on the aortic wall may contribute to aortic dilation. 
However, those studies only focused on the longitudinal WSS component, discarding the 
multidirectional nature of BAV WSS and the potential role played by the circumferential 
WSS component. As a result, bioreactors used in BAV aortopathy studies have consisted 
of cone-and-plate systems subjecting aortic tissue to longitudinal BAV AA WSS. The 
elucidation of the cause-and-effect relationship between BAV WSS and tissue biology 
requires a device capable of replicating the time-varying magnitude and directionality of 
the native WSS. To address this need, this aim describes the design of a novel device 
capable of subjecting multiple tissue samples to time-varying WSS magnitude and 








4.2   Design Principle 
4.2.1 Components Description 
The design principle is based on a cone-and-plate bioreactor, which consists of an 
inverted cone rotating above a stationary plate and driving a fluid flow in the gap 
between the cone and the plate, where c  is the cone angular velocity, cR  is the radius of 
the cone,   is the fluid density,   is the dynamic viscosity,   is the cone angle, 0h  is the 
gap and ( )h r  is the height between the cone and plate at the radial location r  (Figure 
21). As a result, a WSS is exerted on the plate.  
 





c cR  =

 (9) 
where   is the kinematic viscosity [72].  
 Previous study has demonstrated that to produce an axisymmetric, laminar and 
tangential flow, the Reynolds number has to be less than 1. If the Reynolds number falls 
within a range from 1 to 4, secondary flow effects will be present, and as the value goes 









Figure 21. Cone-and-plate bioreactor.  
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4.2.2 Fluid Mechanics of the Cone-and-Plate Device 
The relation between the cone angular velocity and the resultant WSS on the plate 
can be determined by solving the Navier-Stokes and continuity equations. The Navier-






), ii.) purely circumferential flow ( 0 0r zv and v= = ), iii.) rotational 






), iv.) no body force ( 0g = ) and v.) no imposed pressure 






) . In addition, under the assumption of a very 
small cone angle  , the height of the fluid gap can be formulated as 
 ( ) 0 0tanh r h r h r = + = +  (10) 
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Under the assumption of a very small gap between the cone apex and the plate (i.e., 
















 is the dominant term of the equation. The scaled Navier-










This equation can be integrated twice to obtain the tangential velocity equation: 
 1 2v C z C = +  (16) 
From the no-slip conditions at the plate, ( 0) 0v z = = , and at cone, ( ( )) cv z h r r = =  , 



























, where  is the dynamic 














In the limit of a small gap between the cone apex and the plate (i.e., 0 0h → ), 
theoretically, the WSS magnitude generated by the cone rotation is directly proportional 





=  (19) 
 This equation demonstrates the existence of a uniform tangential WSS on the 
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surface of the plate when certain conditions are met (i.e., small cone angle, cone apex 
extremely close to the bottom plate, large cone radius relative to the height of the fluid 
gap, and low Reynolds number to ensure circumferential flow). However, practically, the 
distance between the cone apex and the bottom plate is finite and the WSS becomes 
spatially-dependent on the bottom plate (see Equation 18). Therefore, the design of the 
bioreactor needs to account for the radial dependence of the WSS [49]. 
 
4.3   Design Solution 
4.3.1 Overview 
As demonstrated in Specific Aim 1, the WSS characteristics in TAV and BAV 
AAs not only differ in magnitude but also in directionality (i.e., increased WSS with 
wider angular variations were observed in BAV AAs). Besides, both WSS magnitude and 
directionality change as a function of time. Given that the cone rotation can only produce 





















Figure 22. Culture system schematic 
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achieved by altering the orientation of the tissue specimens mounted on the plate. The 
original cone-and-plate bioreactor design was therefore adapted to implement rotating 
tissue mounts driven by a programmable servo motor. Four tissue mounts were equi-
angularly placed on the bottom plate to minimize the possible flow disturbances caused 
by one sample on the sample immediately downstream, while providing a sufficient 
number of samples to generate statistically meaningful biological results. Perfusion 
pumps were used to circulate culture medium through the system (Figure 22). 
The entire system is composed of four major modules and a driving system. The 
modules include the cone assembly, the tissue mount assembly, the bioreactor case 
assembly and the perfusion system (Figure 23). The driving system include servo/ 
motors. The function and design of each part is described in the following sections and 
the definition of each part is attached in Appendix B.  
 
 
Figure 23. Assembly components. A.) Cone assembly; B.) Tissue mount 
assembly; C.) Bioreactor case assembly 
47  
4.3.2 Cone Assembly 
The cone assembly is responsible for achieving the desired time-dependent WSS 
magnitude. To achieve any desired WSS magnitude, Equation 12 is used, and the 
corresponding angular velocity will then be prescribed for the cone motion. In theory, the 
computed WSS output from the calculated cone angular velocity should match the target 
WSS.  
The cone assembly consists of an inverted cone, a top driving shaft, a top flange 
and a bottom plate container (Figure 24). The dimensions of the cone and the plate were 
determined in the Specific Aim 3 through CFD analysis. The cone has an 80 mm 
diameter and a 179.5° cone angle, and is made of Delrin. The material of the cone was 
chosen based on the previous cone-and-plate bioreactor design [74]. In order to generate 
a WSS distribution on the plate as uniformly as possible, it is required to ensure the cone 
angle is 0.5° from the bottom plate when machining the part.  
 
Figure 24. Cone assembly in cross-sectional view. Showing A.) components and their 
corresponding locations; B.) cone in closer view 
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The top driving shaft is a rotatory step-down shaft made of aluminum (5.00 mm 
diameter, 12.0 mm length; 4.76 mm step diameter, 5.00 mm step length). The step-down 
end of the shaft is connected to the motor shaft through a helical coupling (61005K191, 
McMaster-Carr, Aurora, OH), and the other end of the shaft is connected to the cone.  
The top flange is placed above the cone. The top flange has a 98 mm outer 
diameter, 93.5 mm inner diameter and 8.35 mm thickness, and is made of biocompatible 
stainless steel. It is beneficial to use biocompatible stainless steel, because: 1.) it allows 
direct contact of the culture medium without causing any chemical reaction; 2.) autoclave 
can be performed to ensure the part is sterile and thus prevent contamination problems.  
The plate and the side wall are integrated into one piece, and becomes a bottom 
plate container. The bottom plate container is placed inferior to the cone with a vertical 
distance of 200 µm from the cone apex to the plate. Raised surfaces were created on both 
the top and bottom of the container in order to fit with the edges of the top flange and the 
working fluid reservoir (introduced in section 4.2.4), respectively. The raised surface at 
the top connects to the top flange, and it has a 93.5 mm outer diameter, a 82.0 mm inner 
diameter and a 2.00 mm thickness. The side wall of the container has a 98.0 mm outer 
diameter, a 93.5 mm inner diameter and a 5.88 mm height. The raised surface at the 
bottom connects to the working fluid reservoir, and it has a 98.0 mm outer diameter and a 
93.5 mm inner diameter and a 2.00 mm thickness. Four circular openings (9.00 mm 
diameter) were created 20 mm away from the plate center, and every 90° along the 
circumferential direction on the plate surface (82 mm diameter). These four circular 
openings are where the tissue samples will be located. The entire bottom plate container 
is also made of biocompatible stainless because of the same reasons described previously. 
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4.3.3  Tissue Mount Assembly 
  The tissue mount assembly is responsible for achieving the desired WSS 
directionality. The WSS generated by the cone rotation is always unidirectional. To 
expose the tissue to WSS in different directions, the tissue mounts are rotated as desired, 
which will then render relative orientation to the WSS.  
The tissue mount assembly consists of four tissue mounts, four small driving shafts, 
one large driving shaft, four small driving gears, one large driving gear and five ball 
bearings. The tissue mount is a rotatable structure which was integrated from a circular 
platform and a rotatory step-down shaft, and is made of biocompatible stainless steel. 
The circular platform is 7 mm in diameter and has eight pinholes align along the 
edge. The diameter of the platform was determined according to the previous design, in 
which the tissue samples were 7 mm in diameter. The tissue samples extracted from the 
aortic wall will be fixed on the circular platform by suturing the edge of the tissue 
through the pinholes. The step-down shaft (4.76 mm diameter, 14.0 mm length; 3.18 mm 
step diameter, 11.0 mm step length) is connected to the bottom shaft through helical 
coupling (6208K425, McMaster-Carr, Aurora, OH). The vertical height of the tissue 
mount was designed to be adjustable, in order to adapt the thickness of the tissue sample 
(Figure 25).  
The small driving shaft is an aluminum cylinder (3.18 mm diameter, 28.0 mm 
length) with a small driving gear (57655K33, McMaster-Carr, Aurora, OH) attached to it. 
They are then installed onto a ball bearing (60355K501, McMaster-Carr, Aurora, OH) 
fixed at the bottom of the supporting cylinder (introduced in section 4.2.4). 
The large driving shaft is a rotatory step-down shaft (6.35 mm diameter, 11 mm length; 
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4.76 mm step diameter, 40 mm step length) with a large driving gear installed on the top. 
It is attached to the supporting cylinder with a ball bearing (60355K501, McMaster-Carr, 
Aurora, OH), and connected to the bottom motor shaft through a helical coupling 
(61005K191, McMaster-Carr, Aurora, OH). The large driving gear received the rotatory 
force received from the motor shaft and transports it to the small driving gears. The small 

















Figure 25. Tissue mount in A.) Overview; B.) Cross-sectional view; C.) Top view 
Figure 26. Tissue mount assembly in cross-sectional view 
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4.3.4  Bioreactor Case Assembly 
A working fluid reservoir is placed inferior to the plate, and separates the gearings 
underneath from the fluid stored inside the reservoir. The structure is similar to the 
bottom plate container. The raised surface at the top connects to the bottom plate 
container, and the raised surface at the bottom connects to the supporting cylinder. Seals 
(13125K67, McMaster-Carr, Aurora, OH) are applied at the interface between the tissue 
mounts and the holes on the bottom of the working fluid reservoir to prevent the leaking 
of the fluid.  
The working fluid reservoir combined with the top flange and the bottom plate 
container to form a closed space, which will be filled with culture medium (Dulbecco’s 
Modified Eagle’s Medium-high glucose, Sigma-Aldrich Co., St. Louis, MO; dynamic 
viscosity: 0.00095 kg.m-1s-1). 
 A hollow-carved supporting cylinder is placed inferior to the working fluid 
reservoir to support the cone and tissue assemblies. As mentioned in the previous section, 
the small driving shafts and the corresponding ball bearings from the tissue mount 
assembly are fixed at the bottom of the supporting cylinder. The supporting cylinder has 
a 98.0 mm diameter, and 53.1 mm height, and is made of aluminum. The hollow-carved 










4.3.5  Perfusion System 
Perfusion Pumps 
Two perfusion pumps are required to circulate the culture medium through the 
culture system. One is responsible of transporting the culture medium from the external 
reservoir into the bioreactor, and the other is responsible of returning the excessive fluid 
back to the external reservoir for next round of circulation.  
 The total volume of the culture medium required to fill the bioreactor was 
calculated. The main requirement of the flow rates is that the pumps should be able to 
replenish the total volume of culture medium in the bioreactor every hour. Therefore, 
pumps with flow rates close to or higher than 0.87 mL/ min was required. Based on the 
minimum required flow rate, SP200 OEM Fixed-Flow Peristaltic Pump (APT 
Instruments, Rochester, IL) with a flow rate at 0.92 mL/min was selected. 
Figure 27. Bioreactor case assembly in A.) overview; B.) cross-sectional view 
53  
External Culture Medium Reservoir 
 In order to supply the tissue samples in the bioreactor with fresh culture medium 
for 24 hours, the required amount of the fresh culture medium is 1247 mL. An external 
reservoir was designed in order to store the fresh culture medium before transported into 
the bioreactor. The external reservoir is a rectangular box with a fluid capacity of 1311 
mL (101.6 mm length, 101.6 mm width and 127.0 mm height). The fluid capacity was 
designed to be 10% larger than the required fluid volume. Since the reservoir will directly 
contact with the culture medium, it is made of biocompatible stainless steel. 
 
4.3.6 Driving System 
 Two servo/ motors were required to prescribe cone and tissue mount rotations. 
The motors are chosen from Parker-Hannifin Corporation, Cleveland, OH. Details about 
the determination of the operating conditions and the justification for selecting the motors 
are discussed in Specific Aim 3. Briefly, model number PM-FALR5AM8 was chosen for 
controlling the rotations of the cone and the tissue mounts.  
 Since this system consists of two servo/ motors and it is required that they operate 
at the exact same time steps, Parker Automation Controller (PAC) are added into the 
system to ensure the motors receive the signals and rotate simultaneously. PAC is a 
signal-integrated device. It combines the signals from two separate servos, and ensure the 





4.4  Summary 
 A fluid shear stress bioreactor was designed based on the principle of the cone-
and-plate viscometer, and modification was made at the bottom plate in which the tissue 
sample will be fixed on the free-rotated tissue mount. The desired WSS magnitude and 
directionality were then achieved by the cone and tissue rotation. The CAD drawings for 
each component in the culture system were generated, and model of the perfusion pumps 








SPECIFIC AIM 3 
 
5.1 Rationale 
As mentioned in Specific Aim 2, a fluid shear stress bioreactor has been designed 
based on the principle of cone-and-plate viscometer to subject tissue sample to its native 
WSS environment. In this previous design, the cone is the only component that has 
motion. In order to replicate the WSS directionality, rotating tissue mounts were adapted 
into the current design, and thus changed the model operating environment. Therefore, it 
is required to study if changing the dimensions of the bioreactor will better satisfy 
Equation 18. The operating conditions for this new bioreactor also needed to be 




 The first objective of the CFD analysis was to determine the optimal dimensions 
of the bioreactor. The flow disturbances caused by the wall and tissue rotation effects 
were minimized with the optimal dimensions. The second objective was to determine the 
appropriate operating conditions through an iterative waveform optimization process. The 
third objective was to select the proper servo/ motors based on the operating conditions.  
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5.2.1 Computational Fluid Dynamics (CFD) Models 
 Bioreactor CFD models were created and mesh dependency tests were performed. 
These models were then used in Section 5.2.2 and 5.2.3 for determining the optimal 
dimensions and the operating conditions, respectively, for the bioreactor. 
 
Bioreactor Geometry 
To study how changing the dimensions of the bioreactor will have influences on 
the results, five bioreactors with different dimensions were considered, and the 
corresponding fluid domains in three-dimensions (3D) were created in SolidWorks and 
imported into ANSYS CFX. Owing to the symmetry, only a quarter of the bioreactor 
(i.e., a 90° slice) was created and used for the CFD simulation. This was beneficial for 
saving the computation time. Since there were no fluid-structure interactions involved 
and the focus was on the resultant WSS on the tissue surface, only the fluid domain was 
modeled in this CFD analysis. The fluid domain is the culture medium (Dulbecco’s 
Modified Eagle’s Medium-high glucose, Sigma-Aldrich Co., St. Louis, MO). The density 
and the dynamic viscosity are 1040 kg/m3 and 0.00095 kg.m-1s-1, respectively.  
Two scenarios were considered when determining the dimensions. The first 
scenario took only the radius of the bioreactor ( cR ) (i.e., the distance from the cone apex 
to the lateral wall of the bioreactor) into account, and tissue was kept at the original 
location. In the second scenario, both the radius of the bioreactor and the tissue location (
r ) were manipulated. A total of five models were studied. Model 1 has a radius of 41 
mm, and the distance from the plate center to the tissue center is 20 mm. Model 1 was 
considered as the original model, since the dimensions have been validated previously as 
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a good option for generating uniform WSS. Model 2 and 3 were defined as when both the 
radius and the tissue location increased by 20 percent and 50 percent, respectively. 
Finally, Model 4 and 5 were when only the radius was increased by 50 percent and 100 
percent while maintaining the tissue at same location as in the original model. The other 
parameters, such as the angle of the cone ( ), and the gap between the cone apex and the 
plate ( h ), were kept as the same through all models. The schematic of the bioreactor is as 
shown in Figure 28, and the summary of the dimensions of each model is as listed in 

















Figure 28. Bioreactor schematic (h = 200 µm and α = 0.5˚) 
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Table 9. Model numbers with their corresponding descriptions and dimensions 
Model No. Description R   (mm) r   (mm) 
1 Original 41 20 
2 20% 49.2 24 
3 50% 61.5 30 
4 50%, original tissue location 61.5 20 
5 100%, original tissue location 82 20 
 
Boundary Conditions 
The entire geometry was divided into seven sections, which include the bottom 
plate, the lateral surface, the free surface, the cone surface, the tissue surface, and two 
symmetry sections (Figure 29). The bottom plate was a stationary no-slip wall condition, 
and it was where the tissue samples are placed. The lateral surface was the side wall of 
the bioreactor; therefore, it was assigned a stationary no-slip wall condition as well. The 
free surface is a 1-mm gap between the edge of the cone and the bioreactor wall, and a 
condition of zero shear was imposed. Both the cone surface and the tissue surface were 
assigned a no-slip rotating wall condition. However, when performing the mesh 
dependency test, the tissue surface was not prescribed with any motion. In other words, 
the tissue surface was just a no-slip stationary wall in the mesh dependency test. Finally, 
the symmetry sections were assigned a rotational periodicity boundary condition for the 
symmetric geometry.  
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Mesh Dependency Test 
Mesh dependency test was performed on each model. A constant WSS magnitude 
at 5 Pa was considered as the target. Since the cone angular velocity required for 
generating the target WSS depends on the radius of the tissue location, the corresponding 
speed was calculated for each model by using Equation 18, and is listed in Table 10.  
Since the geometry is thin and curved, the “Proximity and Curvature” was 
selected for the size function, and the relevance center was set as “fine”. Inflation was 
applied at the tissue surface. The mesh was composed of tetrahedral elements and made 
finer in each round by increasing the number of cells across the gap from 3 to 8.  
 After the mesh was generated, a series of simulations were performed under 
steady state. The tissue surface was kept stationary, while the cone surface is rotating at a 
constant angular velocity corresponding to the value of target WSS. Once the simulation 
was completed, the computation time, the total WSS and the torque on the tissue were 
obtained in CFD-post, and recorded for each round. The percent differences then 
calculated and compared between successive mesh refinement. The mesh size was 
free surface (zero shear) 




slip stationary wall) 




Figure 29. Boundary condition at each section 
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determined based on the required computation time of the simulation and the accuracy of 
the results. The most propriate mesh size was the one costed acceptable amount of 
computation time while providing accurate and converged results (i.e., when the results 
show less than 5% change as compared with the previous round). 
 
Table 10. The calculated cone angular velocity for each model for mesh dependency test 
Model No. Description Cone Angular Velocity (Rad/s) 
1 Original 98.6 
2 20% 89.8 
3 50% 81.0 
4 50%, original tissue location 98.6 
5 100%, original tissue location 98.6 
 
5.2.2 Determination of Bioreactor Dimensions 
The addition of the rotating tissue changes the operating environment. Thus, it 
was required to study whether changing the dimensions of the bioreactor will better 
satisfied Equation 18. To perform the analysis, the CFD models created in Section 5.2.1, 
and the target WSS waveforms obtained from the LR-BAV aorta FSI model in Specific 
Aim 1 were used.   
To determine the optimal dimensions of the bioreactor, the bioreactor CFD 
models created in the previous section were switched from steady flow to transient flow. 
The boundary conditions for most sections of the geometry were kept as the same as 
described in the Section 5.2.1. Only slight changes were made on the cone surface and 
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tissue surface, in which both sections were assigned a no-slip rotating wall condition.  
Since the cone rotation is responsible for achieving target WSS magnitude, 
Equation 18 was used in order to convert the target WSS to its corresponding cone 
angular velocity function. This cone angular velocity function was then prescribed to the 
cone surface in the CFD model.  
Inner product was taken on the longitudinal vector ( k̂ ) and the WSS vector ( τ ) 
to obtain the angular variation as a function of time (Equation 7). After the angular 
variation as a function of time was obtained by taking inverse cosine (Equation 8), the 
tissue angular velocity function ( tissue ) was then calculated by taking the derivative of 
the angular variation function (Equation 20). This function was then prescribed to the 
tissue surface in the CFD model. The simulations were performed for two cardiac cycles 







=  (20) 
 
Normalized Root-Mean-Squared Deviation Calculation 
The WSS obtained from each model was then compared with the target WSS by 
calculating the normalized root-mean-squared deviation (NRMSD) as shown in Equation 
21. The smaller value of the NRMSD means the output WSS matches the target WSS 
















5.2.2 Determination of the Operating Conditions 
The determination was carried out on the model selected from the previous 
section. The purpose of this determination was to show that the bioreactor can generate a 
WSS output that matches the target WSS in terms of both magnitude and orientation.  
As mention previously, the WSS magnitude generated on top of the tissue surface 
is directly proportional to the cone angular velocity under ideal conditions. However, the 
CFD analysis showed that the computed WSS on the tissue surface did not perfectly 
match to the target WSS magnitude (Figure 30). The reasons for this discrepancy include 
the fact that the bioreactor geometry was not ideal, and the flow disturbance caused by 
the high rotating speed of the cone and the tissue rotation. In order to achieve the target 




Figure 30. Comparison between the target WSS and the computed WSS output 
in magnitude. The computed WSS deviates from the target at the peak. 
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Strategy Outline 
 Figure 31 is the summary flowchart showing how the operating conditions were 
determined. Generally, any target WSS magnitude is converted to its corresponding 
angular velocity through Equation 18 (block 1-3). This corresponding angular velocity is 
applied to the cone surface in the CFD model, and simulation is performed (block 4). The 
computed ( )t  is then compared to the target, and the goal is to obtain a computed ( )t  
which has a 2R value with the target at least higher than 0.95 and yields a WSS output 
with % error lower than 5.0%. If the criteria are achieved, the WSS input is immediately 
validated (block 5). However, if they are not , then a waveform optimization process is 
required. WSS input is scaled, converted to its corresponding angular velocity, and 
prescribed to the cone rotation (block 6). This process is repeated until the computed 
( )t  passes the criteria. Once the optimized WSS magnitude waveform is determined, 
the WSS angular variation on the tissue is then verified based on the optimized WSS 
magnitude waveform. Same criteria are applied. Details on how the waveform 













Figure 31. Operating condition strategy flowchart. Blue lines represent the general 
process, red lines represent the waveform optimization process for WSS magnitude 
and yellow lines represent WSS angular variation correcting process.  
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Implementation to LR-BAV AA WSS Generation 
 In this determination of the operating conditions, the target WSS waveforms were 
obtained from the proximal convexity AA of the LR-AV aorta FSI model in Specific Aim 
1. The target WSS magnitude waveform was converted to the corresponding angular 
velocity waveform by using Equation 18. Then, this calculated cone angular velocity was 
prescribed to the cone surface in the CFD model.  
  
Waveform Optimization/ Correcting Process 
  Three steps were required for optimizing the WSS magnitude waveform. First 
step was to obtain the scaling factor by taking the ratio of the target and the initial WSS 
magnitude output at every time point. This scaling factor was then applied back to the 
initial WSS magnitude input to obtain a scaled input as the second step (Figure 32). 
Finally, this scaled WSS magnitude input was converted to its corresponding cone 
angular velocity by using Equation 18, and simulation was performed. These steps were 
Figure 32. Comparison between the initial WSS magnitude input and the scaled 
WSS magnitude input 
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repeated, if necessary, until the % error and 2R were less than 5.0% and greater than 
0.95.  
 The verification of the WSS angular variation on the tissue was performed after 
the optimized WSS magnitude input was determined. To calculate the WSS angular 
deviation, the optimized WSS magnitude output was projected along the tangential axis 
by performing inner product on the normalized WSS magnitude output and the 
normalized tangential vector. The definitions of the tangential direction, angular 
deviation and the WSS vector are as illustrated in Figure 33. Black arrow represents the 
tangential direction, which is the ideal flow direction generated by the device. Red dash 
line represents the computed instantaneous WSS vector, which deviates from the ideal 
direction. The angular deviation, , was then obtained by taking inverse cosine from the 
inner product (Figure 34). By adding/ subtracting   from the target, the computed WSS 
angular variation on the tissue was obtained (Figure 35).  
Figure 33. Definition of the tangential direction, angular deviation and 








Figure 34. Error in WSS angle at each time point over the entire cardiac cycle. 
Figure 35. Comparison between the target and computed WSS angular variations.  
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Before correcting the WSS angular variation waveform, another simulation 
without prescribing motion to the tissue was performed. The angular deviations observed 
from both cases were then compared to identify whether it was a result of the tissue 
rotation. The angular deviations and the computed WSS angular variations were obtained 
by following the steps described above, and the results are shown in Figure 36 and 
summarized Table 11. 
The results demonstrated that whether tissue is rotating or not, the WSS angular 
deviations were present, and there are no significant differences between two cases.  In 
other words, the WSS angular deviations was a result of cone rotation. Since that, 
correction on the WSS angular variation waveform could be made by adjusting the tissue 
rotation. Once the corrected WSS angular variation waveform was obtained, and the new 





Figure 36. Comparison of WSS angular deviations between two cases: 1.) with tissue 
rotation and 2.) without tissue rotation. 
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Table 11. The calculated NRMSD and 2R values in WSS angular deviations when 
simulation performed 1.) with tissue rotation and 2.) without tissue rotation 
Case Description NRMSD  
With Tissue Rotation 18.6% 0.921 
Without Tissue Rotation 18.5% 0.922 
 
Normalized Root Mean Squared Deviation Calculation  
 After the simulation with the optimized WSS input was completed, the WSS was 
extracted from the tissue surface. The resultant WSS was then compared with the target 
WSS waveform in terms of the NRMSD (Equation 21) and 2R value.  
 
5.2.3 Torque Calculations for Motor Selections 
 After the operating condition was determined (i.e., the optimized WSS input 
waveform), the torque was calculated based on the angular velocity function derived 
from the optimized waveform. To calculate the torque, the bioreactor was first separated 
into three sections: the cone side the angled face and the cone itself (Equation 22-24).  








=  (22) 









Cone acceleration torque: coneT I=   (24) 
where   is the kinematic viscosity ( 6 2 10.00095 10 m s− − ), c  is the angular velocity, cR  
is the radius of the cone, cH  is the height of the cone, I  is the total inertia and   is the 
2R
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cone acceleration. Th root mean square of the torque was calculated based on the 
summation of the torques and the interval at each time step (Equation 25).  
 










Similar process was performed for calculating the torque for rotating the tissue 
mounts. Since there are four tissue mounts rotating simultaneously, the torque was first 
calculated based on one of them and multiplied by four at the end (Equation 26). 
Torque on the tissue mounts: 






=  (26) 
 
5.3 Results 
5.3.1 Mesh Dependency Test 
 The WSS and the torque extracted from the tissue were compared in each model 
as the number of the cell cross the gap increases. A decreasing trend from four to eight 
cells across the gap was observed in each model for both WSS and torque data (Figure 37 
and Figure 38). 
In Model 1, the percent difference in WSS on the tissue was 5.81% with four cells 
across the gap (vs. three cells across the gap) and it immediately reduced to 3.06% in the 
next mesh setup (i.e., five cells across the gap). On the other hand, the percent difference 
in torque was 12.4 % at the beginning and did not converge (i.e., less than 5%) until the 
number of cell across the gap was increased to six. Since both data do not change 
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dramatically after the cells number reaches six, this setting became the finalized mesh 
setup for Model 1. 
Similarly, the rest of the models show decreasing trend on both data as the number 
of the cells approaches to six. Therefore, six cells across the gap were applied to all the 
model, and used as the finalized mesh setup.  
 
Figure 38. Percent differences between current and successive mesh 
setup in torque on the tissue for each model 
Figure 37. Percent differences between current and successive mesh setup 
in WSS magnitude on the tissue surface for each model. 
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Mesh Properties 
 Mesh properties for each bioreactor model are reported in Table 12. These values 
were obtained when the number of cell across the gap is equal to six. The aspect ratio is a 
measure of the stretching of the cell. Ideal aspect ratio is when the value equals to 1. 
Skewness is the evaluation of the shape of the cell, and it ranges from 0 to 1. The smaller 
the value is means the better the cell quality is. The orthogonal quality and the overall 
element quality were also analyzed, and they both range from 0 to 1 as well. However, 
the larger the value is means the better the cell quality is.  
 
Table 12. Mesh properties (n=6) for each bioreactor models 
 Model 1 Model 2 Model 3 Model 4 Model 5 
Aspect Ratio 1.8394 1.8377 1.8367 1.8382 1.8387 
Skewness 0.2195 0.2193 0.2194 0.2197 0.2201 
Orthogonal Quality 0.7789 0.7791 0.7790 0.7790 0.7783 
Element Quality 0.8412 0.8416 0.8417 0.8414 0.8412 
Number of 
Elements 
9,371,027 11,025,837 13,646,156 13,564,437 17,414,200 
 
5.3.2  Finalized Dimensions 
 The calculated results for NRMSD and 2R  in terms of WSS magnitude and 
angular variation are listed in Table 13 and Table 15, respectively. The lower the 
NRMSD and the greater the 2R  are obtained mean the closer the computed results are to 
the target WSS. Based on the WSS magnitude results, increasing the radius of the 
bioreactor and the tissue location by 20% and 50% did not show significant improvement 
as compared with the original model. Increasing the radius of the bioreactor by 50% and 
100% and keeping the tissue at its original location yielded similar results as compared to 
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the original model; however, it did not significantly improve the % error.  
  The angular variation of the computed WSS on tissue surface was also examined 
for each model. Based on the WSS angular variation results, Model 2 and 3 yielded 
similar results in NRMSD and 2R  values. The NRMSD calculated from Model 4 and 5 
were slightly greater than Model 1; however, the differences were not significant. In 
other words, none of the models was able to demonstrate an improved WSS angular 
variation results as compared to Model 1.   
 Since Model 1 generated the least NRMSD and the greatest 2R  values in WSS 
magnitude, and no significant differences were found in WSS angular variations, 
dimensions of the bioreactor were finalized based on Model 1.  
 
Table 13. The calculated NRMSD and 2R values in WSS magnitude for each model 
Model No. Description NRMSD 2R  
1 Original 5.66% 0.997 
2 20% 6.59% 0.994 
3 50% 8.66% 0.983 
4 50%, original tissue location 5.77% 0.997 







Table 14. The calculated NRMSD and 2R  values in WSS angular variations for each 
model 
Model No. Description NRMSD  
1 Original 19.1% 0.920 
2 20% 19.0% 0.922 
3 50% 19.1% 0.923 
4 50%, original tissue location 19.6% 0.920 
5 100%, original tissue location 19.8% 0.920 
 
5.3.3 Optimized WSS Waveform  
 The scaled (optimized) WSS magnitude input shown in Figure 32 from section 
5.2.2 produced a WSS output as shown in Figure 39. To quantitively assess the 
improvement, NRMSD and  were calculated, and the results show significant 
differences (NRMSD: decreased from 5.66% to 1.16%;  increased from 0.997 to 
0.998, respectively.) 
 The computed WSS angular variations shown in Figure 35 yielded a NRMSD and 
value at 19.1% and 0.920, respectively. By adjusting the tissue rotation according to 
scaled angular variation waveform shown in Figure 40, the results were improved to 
1.1% and 0.999 for NRMSD and , respectively. This demonstrates that the bioreactor 















Figure 39. Comparisons between target, the initial and the optimized 
(post-correction) WSS magnitude 
Figure 40. Comparisons between target, initial, scaled and optimized (post-
correction) WSS angle waveform 
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5.3.4 Servo/Motor Selection 
After the operating conditions were determined, the torque required to perform the 
rotation of such waveform and its RMST were calculated. The selection of the motors 
was then based on the RMST, the average rotating speed, the maximum rotating speed 
and the peak torque, and the values were summarized in Table 15.  
To select motors which are capable of performing this kind of rotation, the stall 
torque, the rated speed, the maximum speed and the peak torque of the motor need to 
match/ be greater than the calculated RMST, average rotating speed, maximum rotating 
speed and peak torque, respectively. By comparing the motor specification from Parker-
Hannifin Corp., PM-FALR5AM8 were selected for the cone rotation and tissue mount 
rotation, respectively. 
 
Table 15. Motor specifications requirement for cone and tissue mount rotations 
Cone Motor Specs  
Average Speed 583.3 RPM 
Max Speed 2323.6 RPM 
Peak Torque 0.000315 Nm 
RMST 0.0092 Nm  
Tissue Mount Motor Specs 
Average Speed -1.2 RPM 
Max Speed 62.8 RPM 
Peak Torque 4.1E-06 Nm 







 In Specific Aim 3, bioreactor CFD models with five different dimensions were 
created. The WSS magnitude and directionality waveforms at the proximal convexity of 
TAV AA obtained from Specific Aim 1 were considered as target, and they were 
programmed for the cone and tissue rotations, respectively, for the simulation. The 
predicted WSS from each model was compared with the target by calculating the 
NRMSD and 2R . Based on the results, Model 1, the bioreactor with original dimensions, 
was selected.  
 The operating conditions for the original bioreactor was determined through the 
waveform optimization process, and an optimized WSS input was generated. By 
prescribing corresponding angular velocity of this optimized WSS input to the cone, the 
WSS output was improved from 5.66% and 0.997 to 1.16% and 0.998 for the NRMSD 
and 2R , respectively.  
 Torque requirements were calculated based on the optimized WSS input and the 
tissues rotation angular velocity. PM-FALR5AM8 (Parker-Hannifin Corp., Cleveland, 










The objectives of this thesis were to quantify the multidirectional characteristics 
of the WSS caused by BAVs in the AA and to design a device capable of subjecting 
native aortic tissue to native BAV WSS magnitude and directionality. The results from 
Specific Aim 1 demonstrated that BAVs not only generated elevated WSS magnitude in 
the convexity of the proximal AA, those elevated WSS also oriented within a wider range 
of angles as compared with TAV. A novel multidirectional fluid shear stress bioreactor 
was then designed based on the principle of a cone-and-plate viscometer to subject aortic 
tissue to TAV/ BAV multidirectional WSS environment. Rotating tissue mounts were 
adapted into the design to achieve the desired WSS directionality, and the WSS 
magnitude was achieved by rotating the cone. Bioreactor dimension analyses were 
performed, and the operating conditions were determined through ANSYS CFX. CAD 
drawings of the bioreactor were created, and the servo/ motors were selected based on the 








7.1 Novelty of the Study 
WSS Characterization 
 In this thesis, the multidirectional characteristics of the WSS in the AA caused by 
BAVs were quantified, and the assessment was done computationally through valve-aorta 
FSI models [43]. The WSS multidirectionality was quantified in terms of TSM, OSI and 
transWSS. TSM and OSI were evaluated in global, and in both longitudinal and 
circumferential directions. Although previous PC-MRI research has also studied the WSS 
characteristics [13], [39], [41], [70], [75], some limitations existed. For instance, the 
recruited samples sometimes involve aortic stenosis, aortic insufficiency, pre-existed 
aortic dilation, aortic aneurysm and other factors which might have influences on the 
flow characteristics [37], [41], [67]. Another limitation is the method which was used to 
extract and analyze the data. Sometimes, the WSS data were extracted and averaged 
along the entire lumen of the AA. The WSS at the convexity and the concavity, which 
could be very different, were not distinguished [39], [75].  
The first novelty of the study is the valve-aorta FSI models used in this thesis 
which include four different aortic valve morphotypes, and they were connected to non-
dilated AA with same dimensions. In this way, morphotype-dependent WSS 
characteristics, if any, would be identified. Other factors (i.e., age, pre-existed aortic 
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dilation, aortic stenosis, etc.), which might affect the flow and WSS characteristics, thus 
were excluded. Furthermore, the data were extracted and analyzed separately at the 
proximal convexity and concavity of the AA in this thesis.  
Although previous research has studied the helical flow pattern observed in the 
BAV AA through quantifying the longitudinal and circumferential components, to the 
best of authors knowledge, the multidirectionality of WSS was never quantified. The 
second novelty of the study is the method proposed in Section 3.2.4. By using this 
method, the angle distribution of the elevated WSS could be identified. WSS 
multidirectinoality was demonstrated at the proximal convexity of all BAV aortas. 
 
Multidirectional Fluid Shear Stress Bioreactor  
The bioreactor designed in this thesis is able to subject time-dependent 
multidirectional WSS to samples. To the best of author’s knowledge, this is the first time 
a fluid shear stress bioreactor capable of replicating both time-varying WSS magnitude 
and directionality introduced. As the interests in the effects of WSS directionality on 
cardiovascular diseases (e.g., atherosclerosis, valvular diseases, aortopathy, etc.) have 
risen, this design will be beneficial for elucidating the cause-and-effect relationship 
between the WSS magnitude/ directionality and the relevant cardiovascular diseases.  
 
7.2 WSS Characteristics in TAV/ BAVs Proximal AA 
WSS Magnitude 
In the proximal AA, all BAVs generated shear stress overload at the convexity, 
with much of the dominant force occurring in the circumferential direction, and 
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underload at the concavity as compared with TAV. This matched previous clinical 
findings [75] and corresponded the asymmetric aortic dilation pattern found in BAV 
patients [27], [54]. The varying magnitude of WSS are always morphotype-dependent, 
and were shown to vary widely depending upon location. Among all BAV models, LR-
BAV generated the most severe time-averaged WSS overload at the convexity, and the 
circumferential component was dominant in all BAV models. Previous clinical research 
found that the aortic dilation in patients with LR-BAV morphotype is asymmetric and 
prone to occur at the root and convexity of the AA, which were also the regions where 
the highest WSS overload was observed in LR-BAV aorta model. 
 
WSS Directionality 
In the proximal convexity, TAV had the highest LOSI among all the models, and 
the COSI were almost zero at the convexity for all the models. In the proximal concavity, 
high LOSI were observed in all the models, as compared to the convexity in which high 
COSI were also observed except for the TAV morphotype. Since the longitudinal TSM 
was the dominant component at both convexity and concavity of the TAV AA plus high 
LOSI and low COSI, this implied that TAV generated unidirectional flow at both regions. 
In contrast, the circumferential TSM was the dominant component at the convexity of all 
BAV AAs, and all BAVs exhibited almost zero COSI and non-zero LOSI. This implied 
that although the flow seemed to be unidirectional along the circumferential direction. 
Based off of this data, it could be assumed that the right-handed helical structure of the 
flow is consistently maintained throughout the entire cardiac cycle, with slight flow 
alterations in the longitudinal direction. Endothelial cells within this region, which 
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experienced lower quantities of WSS and pulsatile flow with reversal in a normal TAV 
morphotype, were now subjected to overloads within a relatively large range of angular 
change. Since the flow was more complicated in BAV AAs as compared to TAV AA, and 
the direction of the flow cannot be assessed simply by evaluating the OSI values.  
To better evaluate the correlation between the WSS multidirectionality and aortic 
dilation, other data must be considered. Based on the polar plots results, all BAV 
demonstrate wider angle coverage with elevated WSS. Among all BAVs, RN-BAV has 
the maximum WSS magnitude value, as well as threshold angular variation. This matches 
the findings suggested in the previous research, where severe flow abnormalities were 
observed in the AA of patients with this morphotype. Furthermore, patients presenting a 
RN-BAV have been associated with a higher risk of obtaining aortic dilation [39].  
TransWSS is the other index that was used to quantify the WSS 
multidirectionality in this thesis. It was quantified based on both the magnitude and 
angular deviation from the reference axis over a period of time. TransWSS can ranges 
from 0 to its total TSM. The closer the value to the total TSM means the flow is more 
multidirectional. Based on the results at the convexity in Figure 20, it showed that 
multidirectional WSS was only presented in the TAV AA. This did not match our 
findings from the polar plots, because this kind of quantification was case-dependent. 
Instead of quantifying the WSS multidirectionality case by case, assessing it by making 
the comparison based on one, normal case (i.e., TAV) will better identify the WSS 




7.3 WSS Angular Deviation from the Circumferential Direction Computed on Tissue 
 Ideally, the shear stress on the tissue surface generated by the cone rotation is in 
the circumferential direction. Based on the results from Specific Aim 3, angular deviation 
was detected from the WSS exerted on the tissue. The discrepancy was observed during 
systolic phase where the cone angular velocity reached its maximum value. This 
suggested that the high rotating speed of the cone caused secondary flow effects in the 
device. Theoretically, increasing the distance of the bioreactor wall from the center 
should mitigate the secondary flow effects caused by the wall. However, based on the 
results from Model 4 and 5 in Specific Aim 3, increasing the distance of the wall by 50% 
and 100% did not improve the WSS orientation results. 
  To solve the problem of WSS angular deviation, two solutions were proposed. 
The first solution is to reduce the cone angular velocity, if possible, to ensure the flow is 
laminar and in the circumferential (i.e., keep Re 1 ). The second solution is taken from 
the advantage of the rotating tissue mount. If the angular velocity prescribed for the cone 
motion cannot be reduced, adjusting the tissue orientation and ensuring the tissue 
alignment in the direction of the computed WSS will solve the problem.  
  
7.4 Limitations of the Study 
   Although the design was verified to be capable of replicating the WSS magnitude 
and directionality, limitation existed in the maximum allowable angular velocity 
programmed for the cone rotation. As mentioned earlier, the Reynolds number must be 
maintained at a very low value (i.e., Re 1 ) in order to keep the flow laminar in the 
circumferential direction. The Reynolds number calculation for this device showed that 
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the value increases as the cone angular velocity increases, and secondary flow effects 
occurred. Based on the bioreactor dimensions and the fluid used in this study, the 
maximum cone angular velocity allowed in order to have a laminar flow in the 
circumferential direction was 89.97 rad/s. In other words, when the operating condition 
for the cone rotation is below 89.97 rad/s., the fluid environment is considered as ideal. If 
not, adjustments either on the cone or the tissue rotation will be required. 
 
7.5 Clinical Implication 
According to the discussion in the previous subsections, two key findings were 
reported. First, WSS overload occurs at the convexity in all BAV models, and the most 
unfavorable overload was found in the LR-BAV aorta model. Second, lower LOSI were 
presented at the convexity of the BAV aorta models as compared with the TAV aorta 
model, and low COSI presented at the convexity of the BAV aorta models relative to its 
concavity. Furthermore, the WSS angle distribution of the elevated WSS at the convexity 
is significant greater in all BAV AAs than TAV AA. Assessing the flow direction 
through the values of LOSI and COSI alone did not provide a complete analysis, since 
OSI does not account for WSS magnitude. Instead, to assess the changes in the flow 
direction, one should first identify the elevated WSS magnitude and then quantify its 
corresponding angle distribution.  
 
7.6 Future Work 
In this thesis, the CAD drawings were created, the operating conditions were 
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determined, and the design was verified through CFD. The next step is to physically 
fabricate the bioreactor and perform biological validation. After these are completed, the 
bioreactor will be utilized in testing the hemodynamic theory of BAV aortopathy in vitro 
and provide new insights into the aortic wall response to native BAV flow abnormalities. 
 Once the existence of the cause-and-effect relationships between native BAV 
hemodynamics and aortic medial degeneration is demonstrated, the bioreactor will guide 
the development of more effective therapeutic strategies for BAV arotopathy based on 






APPENDIX A: Time-varying WSS Vector in the Convexity of Proximal AA for All 
Valve-aorta Models 








APPENDIX B: CAD Drawings of Each Bioreactor Part 
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